Introduction
============

Insect control in U.S. agriculture and residences is currently predominated by the widespread use of pesticides, amounting to \> 90 million pounds annually ([@r9]). This results in dietary exposures from the residues left behind from organophosphorus (OP) and pyrethroid insecticides used on food and animal feed crops \[[@r37]\]. After the 2001 U.S. EPA voluntary phaseout of residential OP use, pyrethroids have become the principal pesticide class used for indoor pest control ([@r36]), creating opportunities for dermal, inhalation, and incidental ingestion exposures ([@r2]). In addition to acute poisonings, epidemiological studies have reported evidence of neurotoxic and developmental effects from OP exposures ([@r3]; [@r12]; [@r30]) and evidence of reproductive toxicity ([@r23]; [@r28]) and endocrine disruption ([@r11]; [@r24]) associated with pyrethroid exposures. In addition, the U.S. EPA has listed permethrin, a widely used pyrethroid for both agricultural and residential insect control, as "likely to be carcinogenic to humans" ([@r38]).

To investigate these potential risks, urinary pesticide metabolites are often used as biomarkers of exposure. Integrating exposures across sources and routes, biomarkers are more likely to give a better indication of actual absorption at the individual level than environmental measures. Urine biomarkers often are examined because they are easier and less invasive to collect than blood or tissue samples. Although all biomarkers are influenced by the timing, magnitude, and frequency of exposure as well as biological clearance rates, for short half-life chemicals with irregular exposure patterns, such as the pyrethroid and OP pesticides, urinary metabolite levels may be especially variable not just between people but even within a person.

When using biomarkers to represent an individual's exposure to these short half-life chemicals, the within-person variability, if not properly accounted for, could lead to exposure measurement error or misclassification and obscure results of epidemiologic investigations and assessments of risk. But researchers have relied on the postulation that the between-person variation in pesticide metabolites, because of both different exposure patterns and metabolic processing of these pesticides, will predominate and differentiate their participants ([@r1]; [@r7]). Investigations of within-person variability are necessary to understand the diversity of exposure and to design effective studies for understanding pesticide effects upon health.

Information on within-person diversity of exposures to OPs and pyrethroids is mounting. In a study of 11 adult males, [@r25] reported that within-person variability in urine concentrations of the OP metabolite 3,5,6-trichloro-2-pyridinol (TCPy) was five times higher than between-person variability with multiple measurements taken over 3 consecutive months. Furthermore, [@r22] reported that the average within-person range of TCPy concentrations in 80 adults with an average of 4.3 measurements over 1 year was 1.5 times higher than the median TCPy concentrations for the study population as a whole.

Estimates of within-person variability based on adult studies, however, may not be valid for children because of differences in exposure patterns (e.g., greater hand-to-mouth contact, time close to the ground, food and liquid ingestion, likelihood of non-food ingestion, and air inhalation, relative to their body size compared with adults) ([@r31]) and differences in biological processing (e.g., higher metabolic rates and immature detoxification processes) ([@r26]; [@r31]). Potential health effects of pesticide exposures are of particular concern in children because their exposures are greater relative to their body weight, and because their organ systems are still developing ([@r18]). Among studies of short duration (up to 7 days), two reported that between-child variability was dominant although within-child variability was still substantial ([@r1]; [@r7]); in a third study population, within-child variability was higher than between-child variability ([@r5]). In a longer-term study of an agriculturally exposed population followed over 21 months, within-child variability accounted for \> 90% of the total variability for nonspecific OP metabolites ([@r8]). To our knowledge, only one study has examined the long-term variability of OP exposures in children from the general population ([@r34]). In that population, there was a nonsignificant predominance of within-child variability for OP metabolites measured in four samples collected over 2 years. Additionally, no study has evaluated the variability of pyrethroid exposures over the long term. More information is needed to understand the extent of variability within the general population.

In the present study, we used numerous repeated-measures data from a study of children's dietary pesticide exposures in Washington state ([@r21], [@r20]) to investigate the extent to which within-child variability contributed to the overall variability in metabolites of OP and pyrethroid pesticides over four seasons of sampling. Second, to shed light on how many samples might be needed in a situation of high within-person variability, we conducted an analysis to assess participant assignment into exposure quartiles according to the number of measurements used.

Methods
=======

*Study design*. This study is part of the Children's Pesticide Exposure Study--Washington (CPES-WA) in which 23 children, 3--11 years of age and living in suburban Seattle, Washington, participated in an organic diet substitution study from 2003 to 2004; details have been reported elsewhere ([@r21], [@r20]). Briefly, the children were recruited from two local public elementary schools and one Montessori preschool. The children participated in consecutive day urine sampling periods in July/August 2003 (median, 15 days; range, 15--16 days); October/November 2003 (median, 12 days; range, 11--13 days); January/February 2004 (median, 7 days; range, 7--8 days); and April/May 2004 (median, 7 days; range, 5--9 days). In the summer and fall sampling periods, an organic diet substitution phase (from day 4 to day 8) was incorporated into the study design to assess the dietary pesticide exposures. For the present study we included only samples collected during the conventional diet portions of the study so that metabolites measured in the urine samples would be representative of typical exposures in the children. Participating children in each session numbered 23 in the summer, 21 in the fall, 20 in the winter, and 19 in the spring. Written informed consent was provided by older children and by the parents of all participants, and oral assent was provided by younger children. The study was approved by the University of Washington Human Subjects Division.

*Urine collection and laboratory analysis*. Each child provided two urine samples per day: the last void before bedtime and the following first morning void. Previous studies have demonstrated that first voids are good predictors of overall daily exposure for OPs ([@r17]), and in combination with last voids, a large portion of the daily exposure is represented. Additional spot urine samples collected at different times of the day during the study were excluded from the present analysis to increase the comparability of the samples evaluated.

After collection, urine samples were stored on ice or refrigerated before processing in the laboratory and then stored at --20^o^C. Samples were analyzed at the National Center for Environmental Health at the Centers for Disease Control and Prevention (CDC; Atlanta, GA) using high performance liquid chromatography--tandem mass spectrometry ([@r29]). Target OP metabolites were malathion dicarboxylic acid (MDA), TCPy, 2-isopropyl-4-methyl-6-hydroxypyrimidinol (IMPy), and 2-diethylamino-6-methyl-pyrmidin-4-ol (DEAMPy). Target pyrethroid insecticide metabolites were 3-phenoxybenzoic acid (PBA), 4-fluoro-3-phenoxybenzoic acid (4F3PBA), *cis*-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid (*cis*-DCCA), *trans*-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid (*trans*-DCCA), and *cis*-2,2-(dibromo)-2-dimethylvinyl-cyclopropane carboxylic acid (DBCA).

*Data analysis*. Metabolite concentrations were adjusted for specific gravity to control for dilution using a reference specific gravity of 1.019 g/cm^3^, the 2007--2008 National Health and Nutrition Examination Survey (NHANES) mean for children 6--11 years of age ([@r6]; [@r19]). Because carryover from a previous day could be expected due to the biological half-life (hours to a couple of days) of these compounds, we confirmed that the conventional diet days following the end of the organic diet portions of the original study were not significantly different from other conventional diet days before including them in the analyses (*t*-test *p*-value \> 0.05).

Intraclass correlation coefficients (ICC), defined as the ratio of between-subject variance to total variance, were calculated as a measure of the reproducibility of measurements over time within individuals. ICCs can range from 0 to 1; ≥ 0.75 indicates excellent reproducibility and ≤ 0.4 indicates poor reproducibility ([@r32]). Between- and within-subject variances were calculated with a linear mixed effects model using maximum likelihood estimation (MLE) modified to account for values below the limit of detection (LOD) and repeated measurements as implemented in SAS 9.3 (SAS Institute Inc., Cary, NC) using PROC NLMIXED, assuming a compound symmetry covariance structure ([@r16]). Age (3--6, 7--11 years), sex, and season were included as covariates in the model:

*Ln*(*Y*) = β~0~ + β~1~(age) + β~2~(sex) + β~3~(season) + *b*~1~ + ε, \[1\]

where *Y* is the metabolite concentration adjusted for specific gravity, *b*~1~ is the between-subject random effect, and ε is the within-subject error.

For metabolites with high percentages of nondetects, the model's stipulation of a normal distribution of the data was difficult to evaluate. Therefore, we restricted the ICC analyses to the four metabolites (MDA, TCPy, PBA, and *trans*-DCCA) that were \> LOD in \> 50% of samples. Data were natural log-transformed before analysis. We performed a sensitivity analysis on the calculation of the ICCs by substituting LOD/2 for values \< LOD and using an unmodified NLMIXED procedure. A further sensitivity analysis was used to test the model's sensitivity to the assumption of equal covariance. The ICC calculations were repeated using a subset of the data with an equal covariance pattern, where only samples with at least 2 intervening days were included in the subset per season.

To address how much exposure misclassification may develop when participants are categorized into exposure groups and how many samples may be necessary to improve the categorization, we performed surrogate category analyses for the first and last voids separately ([@r14]; [@r40]) with an additional scoring step ([Figure 1](#f1){ref-type="fig"}). We calculated the geometric mean value of a metabolite across all samples collected from each participant, resulting in 23 participant mean values. Next, we assigned each participant to an exposure quartile (a "surrogate category") based on the metabolite concentration of a single sample selected at random from each participant's pool of samples. Then we populated each surrogate category with the children's geometric means and calculated the group grand means. Then we evaluated the performance of the category assignment. It would not be possible to directly determine whether individuals were correctly assigned according to their "true" and unobserved distribution in the population; however, if surrogate categories were correctly assigned, the mean value of each category should increase monotonically from the lowest to the highest exposure category. If this were the case, we assigned the run a score of 1, and 0 otherwise. Then we repeated the sampling and classification steps 1,000 times and used the mean value of the 1,000 scores (expressed as a percentage) to indicate an average "success rate." We performed this process three additional times based on the mean value of two, three, and four randomly selected samples for each participant. For this analysis, we substituted instrument-read values (when available), or the LOD/2, as the concentration for all samples with measurements \< LOD.

![Process of surrogate category analysis with scoring. GM, geometric mean.](ehp.1306737.g001){#f1}

Results
=======

A total of 1,215 urine samples were collected from 23 children (15--63 per child, with a median of 59) during the conventional diet stages of the study over four seasons. Metabolite frequency of detection, and distributions, adjusted for specific gravity for first and last voids, are presented in [Table 1](#t1){ref-type="table"}. Summary statistics of unadjusted levels for both the conventional and organic diet parts of the sampling were previously reported ([@r21], [@r20]). The frequency of detection varied among the metabolites. Those detected most frequently across all measurements were PBA (\> 85%), a common metabolite of several pyrethroids, and TCPy, a specific metabolite of chlorpyrifos (\> 81%). Several metabolites were detected \< 20% of the time, including the pyrethroid metabolites 4F3PBA and DBCA (specific metabolites of cyfluthrin and deltamethrin, respectively), and the OP metabolites IMPy and DEAMPy.

###### 

Descriptive statistics of first and last void concentrations of urinary metabolites adjusted for specific gravity from 23 children.

  Metabolite                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Void    Total no. of urine samples   LOD (μg/L)   Detection frequency (%)   Percentile                              
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ---------------------------- ------------ ------------------------- ------------ -------- -------- -------- -------
  Pyrethroid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  PBA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 First   616                          0.1          91                        0.5          1.1      1.5      4.5      61.2
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.1                          85           0.3                       1.0          1.4      4.1      26.5     
  4F3PBA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              First   599                          0.2          16                        \< LOD       \< LOD   \< LOD   1.1      2.3
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.2                          13           \< LOD                    \< LOD       \< LOD   1.0      61.2     
  *cis*-DCCA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          First   599                          0.2          37                        \< LOD       \< LOD   0.7      1.7      46.0
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.2                          32           \< LOD                    \< LOD       0.4      1.3      4.6      
  *trans*-DCCA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        First   599                          0.4          55                        \< LOD       0.9      1.4      4.4      97.1
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.4                          49           \< LOD                    0.6          1.3      3.9      27.7     
  DBCA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                First   599                          0.1          3                         \< LOD       \< LOD   \< LOD   \< LOD   0.3
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.1                          4            \< LOD                    \< LOD       \< LOD   \< LOD   0.8      
  OP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  MDA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 First   616                          0.3          57                        \< LOD       0.8      3.0      13.8     433.8
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.3                          52           \< LOD                    0.6          3.2      16.9     283.8    
  TCPy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                First   616                          0.2          87                        1.0          3.8      6.8      13.0     43.8
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                599     0.2                          81           0.8                       3.2          6.0      12.2     69.5     
  IMPy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                First   600                          0.7          3                         \< LOD       \< LOD   \< LOD   \< LOD   16.2
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                586     0.7                          4            \< LOD                    \< LOD       \< LOD   \< LOD   31.4     
  DEAMPy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              First   597                          0.2          10                        \< LOD       \< LOD   \< LOD   0.6      26.7
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                593     0.2                          18           \< LOD                    \< LOD       \< LOD   1.5      50.2     
  Abbreviations: DBCA, *cis*-2,2-(dibromo)-2-dimethylvinyl-cyclopropane carboxylic acid; *cis*-DCCA, *cis*-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid; *trans*-DCCA, *trans*-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid; DEAMPy, 2-diethylamino-6-methyl-pyrmidin-4-ol; IMPy-2-isopropyl-4-methyl-6-hydroxypyrimidinol); MDA, malathion dicarboxylic acid; OP, organophosphorus; PBA, 3-phenoxybenzoic acid; 4F3PBA, 4-fluor-3-phenoxybenzoic acid; 3,5,6-trichloro-2-pyridinol; TCPy, 3,5,6-trichloro-2-pyridinol.                                                                                                                       

Within-subject variability was the larger component of variance across all analytes, making up \> 65% of the total variability in first voids and last voids ([Table 2](#t2){ref-type="table"}). The ICCs ranged from 0.29 to 0.35 among the pyrethroid metabolites and 0.08 to 0.12 for the OP metabolites, demonstrating that within-subject variability exceeded between-subject variability by a factor of 2--11.

###### 

Components of variance^*a*^ and intraclass correlation coefficients for first and last voids.

  Metabolites                                                                                                                                                                                                                                                                                                                         First void   Last void                                    
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------ ----------- ------ ------ ---- ------ ------ ------
  PBA                                                                                                                                                                                                                                                                                                                                 91           0.48        0.97   0.33   85   0.47   1.16   0.29
  *trans*-DCCA                                                                                                                                                                                                                                                                                                                        55           0.45        0.88   0.34   49   0.49   0.91   0.35
  MDA                                                                                                                                                                                                                                                                                                                                 57           0.36        4.04   0.08   52   0.56   4.88   0.10
  TCPy                                                                                                                                                                                                                                                                                                                                87           0.21        1.75   0.11   81   0.29   2.09   0.12
  Abbreviations: *trans*-DCCA, *trans*-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid; MDA, malathion dicarboxylic acid; OP, organophosphorus; PBA, 3-phenoxybenzoic acid; TCPy, 3,5,6-trichloro-2-pyridinol. ^***a***^Age, sex, and season were included as covariates. Metabolite concentrations were ln-transformed.                                                             

A seasonal effect on the ratio of within- and between-subject variability was observed when the same model was fit separately for each season. Compared with the overall results, ICCs increased in the fall, winter, and spring, especially for the last voids of TCPy (up to 0.59) ([Figure 2](#f2){ref-type="fig"}). However, none reached a level considered to be a highly reproducible measure (\> 0.75). For the pyrethroids ([Figure 3](#f3){ref-type="fig"}), ICCs continued to have a large contribution of within-subject variation, although summer and winter ICCs reached or exceeded 0.5. Where ICCs increased, the within-subject variance had decreased while the between-subject variance had increased relative to the full model.

![OP metabolite intraclass correlation coefficients of first and last voids by season.](ehp.1306737.g002){#f2}

![Pyrethroid metabolite intraclass correlation coefficients of first and last voids by season.](ehp.1306737.g003){#f3}

The surrogate category analysis indicated that when a single sample was used to categorize exposure into quartiles, the quartile mean values increased monotonically only 14--51% of the time ([Table 3](#t3){ref-type="table"}). Single samples were least likely to produce monotonically increasing quartiles for the OP metabolite MDA, and most likely to do so for the pyrethroid metabolite PBA. As the number of samples increased, the rate of successful ranking improved, to the point that PBA reached a 78% success rate with four first morning samples, and an 86% success rate for four evening samples.

###### 

Surrogate category analysis based on 1--4 random samples in 1,000 resamples.

  Metabolites                                                                                                                                                                                                                                                                                                                                                                                                                                                        Void    1 Sample success rate (%)   2 Sample^*a*^ success rate (%)   3 Sample^*a*^ success rate (%)   4 Sample^*a*^ success rate (%)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------- --------------------------- -------------------------------- -------------------------------- --------------------------------
  PBA                                                                                                                                                                                                                                                                                                                                                                                                                                                                First   47                          50                               73                               78
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                               51      61                          79                               86                               
  *trans*-DCCA                                                                                                                                                                                                                                                                                                                                                                                                                                                       First   48                          47                               67                               71
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                               48      50                          66                               78                               
  MDA                                                                                                                                                                                                                                                                                                                                                                                                                                                                First   15                          31                               52                               59
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                               14      32                          55                               66                               
  TCPy                                                                                                                                                                                                                                                                                                                                                                                                                                                               First   19                          34                               44                               55
  Last                                                                                                                                                                                                                                                                                                                                                                                                                                                               32      41                          59                               66                               
  Abbreviations: *trans*-DCCA, *trans*-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid; MDA, malathion dicarboxylic acid; PBA, 3-phenoxybenzoic acid; TCPy, 3,5,6-trichloro-2-pyridinol. Results indicate the success rate of all resamples that produced monotonically increasing quartiles. ^***a***^In runs with two or more random samples, children were assigned to quartiles according to the mean of the logged values of the selected samples.                                                                                                         

Discussion
==========

Our analyses demonstrated that most of the variance in repeated measures of OP and pyrethroid metabolites was attributable to within-subject variability in both the first and last voids of the day, with some variation in the extent of within-person variability according to season. The low ICCs we observed indicated poor reproducibility of a single measurement and the need for repeated sampling to characterize individuals' exposures appropriately.

Seasonal variability in ICCs may offer insight into exposure sources. For the OPs, ICCs were larger in fall through spring than in the summer, which may reflect seasonal variation in food sources. Diet has been shown in previous studies to be a primary contributor to urinary OP levels ([@r4]; [@r20]; [@r27]), and imported fruits and vegetables have been found to have higher levels of OP residues than domestic produce ([@r37]). ICCs for both pyrethroid metabolites were higher in the summer than in the fall or spring. This might reflect increased use of pesticides to treat pests by those who use pesticides, which would result in more consistent environmental exposures, and thus reduced within-person variability. However, this would not explain high ICCs for *trans*-DCCA during the winter.

As a result of having many repeated measures, we were able to investigate how many samples would be sufficient to create quartiles of increasing exposure levels of participants for the entire period. Although this exploration does not indicate whether participants have been assigned to the correct quartile, it does indicate whether the quartile averages follow expected stepwise increases, which is a good starting point for any epidemiological investigation. Monotonically increasing quartiles were produced only 14--32% of the time when OP exposures were categorized based on a single sample measurement, but increased to 55--66% when categorization was based on the mean value of four samples. For pyrethroids, monotonically increasing quartiles resulted about 50% of the time when based on a single measurement, but increased to 71--86% when categorization was based on the mean value of four samples. These findings suggest that having a small number of samples from each study participant may lead to a high probability of exposure misclassification by incorrect quantile assignment and offer little assurance for correctly classifying the exposure into a specific category.

The degree of within-person variability seen in the CPES-WA children was consistent with prior studies of children's exposures to OPs, although those relied primarily on fewer samples per person for their calculations. Similar to our study, when samples were spread over time (2 weeks to 1 year), ICCs were low (0.02--0.3), indicating a strong contribution of within-person variability ([@r8]; [@r13]; [@r25]; [@r34]; [@r39]). These low ICCs were observed across different exposure scenarios: occupational parental exposure, residence in proximity to agricultural fields, and urban and suburban general population level exposure. When samples were taken in closer proximity to each other, as for six samples taken within 48 hr in the U.S. EPA study of preschool children in Ohio and North Carolina, ICCs were higher (0.44--0.65) ([@r7]). This indicated a greater contribution of between-child variability, but still such a substantial contribution of within-child variability that authors expressed concern about the utility of using one sample to rank participants' 48-hr exposure levels ([@r7]). However, a recent study of agriculturally exposed children found low ICCs for samples taken over a single week (0.27--0.35) ([@r5]). Similar to our study, between-subject variability increased when ICCs were calculated by season in a study of turf workers sampled up to 18 times for five pesticides ([@r13]). For pyrethroids, only a single study is available for comparison though with a much shorter time frame (2 days). The Ohio U.S. EPA study authors reported an ICC of 0.69, which, again, they suggested was not high enough to merit using single spot samples to represent the 2-day sampling period ([@r7]).

Our study's generalizability could be limited by the study population's characteristics that could influence pesticide exposures patterns and their absorption and metabolism. All children in the present study originated from the Seattle area, were Caucasian, and were of a mid- to upper range of socioeconomic status in relation to average U.S. levels. Although a direct comparison to NHANES is not possible due to its cross-sectional nature, the present study's mean values over all samples collected during the conventional diet days for PBA, *trans*-DCCA, and TCPy were similar to mean values based on single spot urine samples collected from 6- to 11-year-old NHANES participants in 1999--2000. However, MDA was rarely detected in samples from the NHANES participants, and concentrations were much lower \[95th percentile values of 2 ng/mL compared with 16 ng/mL in the present study; lower percentiles were \< LOD (2.64 ng/mL)\]. Although participation in the diet intervention may have made the families more conscious of their pesticide use over time, pesticide use by families was indeed reported, and the means of postorganic conventional diet portions were equivalent to or higher than preorganic portions (data not shown). We were also limited by the small number of children in the study. However, our finding of low ICCs for the pesticides evaluated is consistent with previous studies, which suggests that high within-person variability may be common across populations. Our analysis lacked replicate samples (split samples measured again on the same day or a different day) to examine the contribution of the method variability to the overall variability. However, even with a worst-case scenario of a 25% coefficient of variation (CV), our method variability could at most contribute 7% of the within-person variability. Methods commonly used for these compounds report CVs for quality controls at \< 10% ([@r29]). Also, a limit of quantitation (LOQ) was not provided by the laboratory, so we used the LOD as the censoring point in our statistical analysis. However, when we employed an estimated LOQ of LOD × 3 as the censoring point, we observed ICCs very similar to those obtained using the LOD (at most increased by 0.09; data not shown). A further limitation of the method was its reliance upon an assumption of equal covariance among the repeated measures within a subject by requiring a compound symmetry covariance structure. However, a sensitivity analysis using a subset of the data conforming to compound symmetry structures (samples with at least 2 intervening days) produced similar ICCs.

The use of an MLE approach that includes the samples \< LOD in the estimation of the likelihood was a strength of our ICC analysis; this allowed us to employ the entire data set without relying on the use of substitute values. This method is not widely used in exposure assessment and environmental epidemiology to incorporate values \< LOD, although it can provide estimators that are consistent, asymptotically unbiased, and efficient ([@r16]). Other methods used to account for values \< LOD, including substitution of censored values with the LOD/2 or LOD/~√~^--^2, model-based multiple imputation, or reverse Kaplan--Meier estimation, cannot accommodate both repeated measurements and censored values ([@r16]). Through modeling, [@r16] demonstrated the general improved performance of a customized MLE method over substitution in estimating group means, differences in group means, and within-subject variances, especially with large percentages of values \< LOD. However, in specific scenarios of low sample numbers, high geometric standard deviation, and/or high detection frequencies, more common techniques may be equivalent or preferable. In our data, when the method was repeated with LOD/2 substitution, ICCs were higher for the pyrethroids but were approximately the same for the OPs (data not shown).

The high within-child variability and low categorization success rates demonstrated here have implications for epidemiological studies and risk assessment of children's exposure to pesticides and health effects. Although researchers need to balance the costs and administrative load of measuring an appropriate number of people an adequate number of times, substantial random within-person errors can result in attenuated coefficients of regression and correlation, as well as bias risk estimates toward the null for continuous data and in either direction for categorical data ([@r40]). To provide an example of the effect of the within-subject variability upon a true risk estimate, we employed the formula of [@r15] derived from [@r33] for a case--control study with matched sets: RR~obs~ = exp\[ICC × ln(RR~true~)\], where RR indicates relative risk. For a true odds ratio of 2, our ICCs suggest that estimated odds ratios in studies might be as low as 1.06 (using the lowest ICC of 0.08 for MDA) to 1.27 (using the highest ICC of 0.35 for *trans-*DCCA), suggesting the possibility of substantial bias that could result in false negative findings. Large studies are not immune to the effects of variability in exposure measurement. Attenuation bias reflects high within-subject variance when measuring risk factors (relative to between-subject variance) and is not reduced by increased sample size, as demonstrated in the Framingham Heart Study ([@r33]). Future researchers may want to consider methods for estimate adjustment or sensitivity/bias analysis to address measurement error and within-person variability in their studies ([@r10]; [@r33]; [@r35]). Our ICCs may be useful reference values in studies of children's pesticide biomarkers where internal validation data are not available for conducting sensitivity analyses.

In addition to better characterizing average exposures, collecting repeated samples of a short half-life chemical such as these pesticides enables a better understanding of exposure patterns and identification of extreme values. Without longitudinal data, the ability to capture trends over time or over season will be lost. Repeated measures also provide more opportunities to identify risk factors for heightened exposures, and therefore provide insight on how to reduce exposures. In this population, intermittent urinary metabolite peaks were observed and then traced back to parental uses of pesticides in or around the home ([@r20]).

In conclusion, the short half-life pyrethroid and OP pesticides exhibited substantial within-subject variability as urinary biomarkers in children when observed over four seasons of measurements. Researchers investigating exposure and risk patterns in children and links to health outcomes may need repeated measurements to derive accurate findings.
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